← Leaderboards
Ralph A. Reisfeld
Scripps Research Institute
$4,219,650
Attributed
$4,219,650
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $720.7K · FY2006–11$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$4,219,650 · 4
By mechanism
R01$4,105,153 · 3
R21$114,497 · 1
Top collaborators
No co-investigators on record.
Most similar at Scripps Research Institute
Same institution · by research overlap
- Linda M Columbus$5,589,545
- J. Lindsay Whitton$31,825,279
- Michael B Oldstone$35,619,947
- Michael Buchmeier$13,319,318
- Ralph Feuer$1,675,509
Others in their field
Top investigators on “Salmonella Typhimurium”
- Jorge E Galan · Yale University$27,917,656
- Andreas J Baumler · Texas A&M University Health Science Ctr$21,644,776
- Ferric C Fang · University Of Washington$20,288,270
- Roy Curtiss · Washington University$20,061,438
- Ramnik J Xavier · Broad Institute, Inc.$14,140,132
- Denise M. Monack · Stanford University$14,023,917
Research focus
Salmonella TyphimuriumNeoplasm /Cancer ImmunotherapyAnimalsMammary NeoplasmsMemoryMolecularDesignLongevityAdverse EffectsChemokineImmuneLaboratory MouseIn VivoBaseMacrophageCd8b1 GeneEvaluationLifeBreast Cancer CellBreast Cancer ModelApoptosisCellsCytokineMediating
Grant awards (12)
Targeting of STAT3 Signaling Enhances Efficacy of Breast Cancer Immunotherapy$382,222
R01 · FY2011 · CA · contact PI
Targeting of STAT3 Signaling Enhances Efficacy of Breast Cancer Immunotherapy$394,043
R01 · FY2010 · CA · contact PI
Targeting of STAT3 Signaling Enhances Efficacy of Breast Cancer Immunotherapy$394,043
R01 · FY2009 · CA · contact PI
Fra-1: A new target for a genomic breast cancer vaccine$326,609
R01 · FY2009 · CA · contact PI
Fra-1: A new target for a genomic breast cancer vaccine$326,609
R01 · FY2008 · CA · contact PI
Fra-1: A new target for a genomic breast cancer vaccine$320,404
R01 · FY2007 · CA · contact PI
Fra-1: A new target for a genomic breast cancer vaccine$329,973
R01 · FY2006 · CA · contact PI
NOVEL STRATEGIES FOR THE IMMUNOTHERAPY OF COLON CANCER$416,700
R01 · FY2003 · CA
NOVEL STRATEGIES FOR THE IMMUNOTHERAPY OF COLON CANCER$416,700
R01 · FY2002 · CA
NOVEL STRATEGIES FOR THE IMMUNOTHERAPY OF COLON CANCER$398,925
R01 · FY2001 · CA
NOVEL STRATEGIES FOR THE IMMUNOTHERAPY OF COLON CANCER$398,925
R01 · FY2000 · CA
IMMUNOTHERAPEUTIC MODULATION OF ANGIOGENESIS IN CANCER$114,497
R21 · FY2000 · CA